Creative Planning’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Creative Planning’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-52	Closed	-$3.92K	–	3067
2023 Q2	$3.92K	Hold	52	–	–	﹤0.01%	2578
2023 Q1	$4.39K	Hold	52	–	–	﹤0.01%	2491
2022 Q4	$7.09K	Hold	52	–	–	﹤0.01%	2376
2022 Q3	$5K	Hold	52	–	–	﹤0.01%	2261
2022 Q2	$12K	Hold	52	–	–	﹤0.01%	2184
2022 Q1	$15K	Hold	52	–	–	﹤0.01%	2170
2021 Q4	$11K	Hold	52	–	–	﹤0.01%	2053
2021 Q3	$24K	Hold	52	–	–	﹤0.01%	2040
2021 Q2	$31K	Sell	52 -3	-5%	-$1.59K	﹤0.01%	1969
2021 Q1	$34K	Buy	55 +3	+6%	+$1.93K	﹤0.01%	2398
2020 Q4	$23K	Hold	52	–	–	﹤0.01%	2176
2020 Q3	$20K	Buy	52 +4	+8%	+$4.36K	﹤0.01%	1982
2020 Q2	$36K	Hold	48	–	–	﹤0.01%	1789
2020 Q1	$40K	Hold	48	–	–	﹤0.01%	1659
2019 Q4	$49K	Hold	48	–	–	﹤0.01%	1824
2019 Q3	$72K	Hold	48	–	–	﹤0.01%	1757
2019 Q2	$55K	Buy	+48	New	+$64K	﹤0.01%	1807

Other funds holding VCNX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Creative Planning's VCNX Position: Q3 2023 in Review

Creative Planning sold out of Vaccinex, Inc. Common Stock (VCNX) in Q3 2023, closing a stake of 52 shares — an estimated $3.92K sold.

Creative Planning first reported a position in VCNX in Q2 2019 and held it in 17 quarters. The position peaked at $72K in Q3 2019. 18 funds tracked by Wall St. Rank hold VCNX as of Q3 2023.

Creative Planning reported no remaining Vaccinex, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Creative Planning sold 52 Vaccinex, Inc. Common Stock shares in Q3 2023, an estimated $3.92K.
Creative Planning first reported a position in Vaccinex, Inc. Common Stock in Q2 2019 and held it in 17 quarters.
Creative Planning's Vaccinex, Inc. Common Stock position peaked at $72K in Q3 2019.
18 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q3 2023.

Based on Creative Planning's 13F filing for Q3 2023, filed 16 Nov 2023.